ML4000

N/A

Report date: 2023/03/10 15:12:51
NME

Base Information

Drug NameML4000
Drug Alias NameML-4000ML4000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitorsArachidonate 5-lipoxygenase inhibitors
TargetsCyclooxygenase-1Cyclooxygenase-2Arachidonate 5-lipoxygenase
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Chase Sun Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Chase Sun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A